CC
RDUS

Centiva Capital’s Radius Health, Inc. RDUS Stock Holding History

Centiva Capital’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,004
Closed -$97K – 1953
2021
Q4 		$97K Buy
+14,004
New +$205K ﹤0.01% 1059

Other funds holding RDUS

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Centiva Capital's RDUS Position: Q1 2022 in Review

Centiva Capital sold out of Radius Health, Inc. (RDUS) in Q1 2022, closing a stake of 14,004 shares — an estimated $97K sold.

Centiva Capital first reported a position in RDUS in Q4 2021 and held it in 1 quarter. The position peaked at $97K in Q4 2021. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2022.

  • Centiva Capital reported no remaining Radius Health, Inc. position as of Q1 2022 after selling out during the quarter.
  • Centiva Capital sold 14,004 Radius Health, Inc. shares in Q1 2022, an estimated $97K.
  • Centiva Capital first reported a position in Radius Health, Inc. in Q4 2021 and held it in 1 quarter.
  • Centiva Capital's Radius Health, Inc. position peaked at $97K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2022.

Based on Centiva Capital's 13F filing for Q1 2022, filed 16 May 2022.